Neutralization sensitivity of Omicron BA.2.75 to therapeutic monoclonal antibodies

NCATS Open Data2022-07-22 更新2026-08-08 收录

新冠病毒变异株中和敏感性

单克隆抗体疗效评估

数据链接：

https://doi.org/10.1101/2022.07.14.500041 数据链接链接失效反馈

官方服务：

资源简介：

Neutralization sensitivity of Omicron BA.2.75 to therapeutic monoclonal antibodies

创建时间：

2022-07-15

surrogate responses and sotrovimab

药物转录组学

单克隆抗体疗效评估

- accessions_metadata_nopatid.tsv contains the accession id, the day and treatment information - counts.tsv contains the tpm (transcripts per million) matrix for the respective accession ids.

Figshare2022-07-17 更新100

A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of CFZ533 in Patients With Primary Sjögren's Syndrome

干燥综合征药物临床试验

单克隆抗体疗效评估

This study did evaluate the safety,tolerability and preliminary therapeutic efficacy of multiple doses of intravenous infusion of CFZ533 monoclonal antibody in patients with primary Sjögren's syndrome

DataCite Commons2025-12-16 更新10

Genetic barrier to resistance: a critical parameter for efficacy of neutralizing monoclonal antibodies against SARS-CoV-2 in a non-human primate model

单克隆抗体疗效评估

病毒抗性突变检测

Monoclonal antibodies are a powerful tool for the prophylaxis and treatment of acute viral infections. Hence, they were one of the first therapeutic agents licensed for the treatment of SARS-CoV-2. Of

NIAID Data Ecosystem10

Guselkumab (interleukin-23-specific monoclonal antibody) demonstrates clinical and molecular response in moderate-to-severe psoriasis

银屑病靶向治疗

单克隆抗体疗效评估

Guselkumab (interleukin-23-specific monoclonal antibody) demonstrates clinical and molecular response in moderate-to-severe psoriasis

ChEBI2014-05-14 更新30

In vivo neutralization of HBV infection by monoclonal antibodies (mAbs).

乙型肝炎病毒中和

单克隆抗体疗效评估

n.d.: not detected.In vivo neutralization of HBV infection by monoclonal antibodies (mAbs).

Figshare2015-12-03 更新10